Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma
- 122 Downloads
Available data suggest that respiratory infections are associated with increased morbidity and mortality in patients hospitalized due to acute leukemia and allogeneic stem cell transplantation (allo-SCT). However, the precise incidence, risk factors, and severity of respiratory infection, mainly community-acquired, in patients with lymphoma and multiple myeloma (MM) are not fully determined. The current study aimed to investigate risk factors for respiratory infections and their clinical significance in patients with B cell non-Hodgkin lymphoma (NHL) and multiple myeloma (MM) in the first year of diagnosis.
Data of consecutive patients diagnosed with NHL or MM and treated at the Rambam Hematology Inpatient and Outpatient Units between 01/2011 and 03/2012 were evaluated. Information regarding anticancer treatment, incidence and course of respiratory infections, and infection-related outcomes was analyzed.
One hundred and sixty episodes of respiratory infections were recorded in 103 (49%) of 211 (73-MM, 138-NHL) patients; 126 (79%) episodes were community-acquired, 47 (29%) of them required hospitalization. In univariate analysis, age < 60 years, MM diagnosis, and autologous SCT increased the respiratory infection risk (P = 0.058, 0.038, and 0.001, respectively). Ninety episodes (56% of all respiratory episodes) were examined for viral pathogens. Viral infections were documented in 25/90 (28%) episodes, 21 (84%) of them were community-acquired, requiring hospitalization in 5 (24%) cases. Anti-flu vaccination was performed in 119 (56%) patients. Two of the six patients diagnosed with influenza were vaccinated.
Respiratory infections, including viral ones, are common in NHL and MM. Most infections are community-acquired and have a favorable outcome. Rapid identification of viral pathogens allows avoiding antibiotic overuse in this patient population.
KeywordsMultiple myeloma Non-Hodgkin lymphoma (NHL) Respiratory infection Viral infection
The authors would like to thank Sonia Kamenetsky for the preparation of this manuscript.
Compliance with ethical standards
The current retrospective study was approved by the Institutional Review Board of the Rambam Health Care Campus in Haifa, Israel (approval no. 0229-13).
Conflict of interest
The authors declare that they have no conflicts of interest.
- 2.Maschmeyer G, Carratala J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J, Neumann S, Rieger C, Ruhnke M, Salwender H, Schmidt-Hieber M, Azoulay E (2015) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26(1):21–33. https://doi.org/10.1093/annonc/mdu192 CrossRefPubMedGoogle Scholar
- 3.Cheuk DK, Chiang AK, Lee TL, Chan GC, Ha SY (2011) Vaccines for prophylaxis of viral infections in patients with hematological malignancies. Cochrane Database Syst Rev CD006505Google Scholar
- 5.Campbell AP, Chien JW, Kuypers J, Englund JA, Wald A, Guthrie KA, Corey L, Boeckh M (2010) Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. J Infect Dis 201(9):1404–1413. https://doi.org/10.1086/651662 CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D, Weisser M, Gratwohl A, Fluckiger U, Hirsch HH (2008) Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 46(3):402–412. https://doi.org/10.1086/525263 CrossRefPubMedGoogle Scholar
- 10.Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P (2013) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 56(2):258–266. https://doi.org/10.1093/cid/cis844 CrossRefPubMedGoogle Scholar
- 17.Mikulska M, Del Bono V, Gandolfo N, Dini S, Dominietto A, Di Grazia C, Bregante S, Varaldo R, Orsi A, Ansaldi F, Bacigalupo A, Viscoli C (2014) Epidemiology of viral respiratory tract infections in an outpatient haematology facility. Ann Hematol 93(4):669–676. https://doi.org/10.1007/s00277-013-1912-0 CrossRefPubMedGoogle Scholar
- 18.Teh BW, Worth LJ, Harrison SJ, Thursky KA, Slavin MA (2015) Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital. Support Care Cancer 23(7):1901–1906. https://doi.org/10.1007/s00520-014-2550-3 CrossRefPubMedGoogle Scholar
- 21.Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M (2013) Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev CD008983Google Scholar